RBC Capital analyst Conor McNamara initiated coverage of Natera (NTRA) with an Outperform rating and $251 price target The firm says Natera is ...

Reigning Horse of the Year Thorpedo Anna has taken over the leading position on the NTRA Top Thoroughbred Poll, with 16 first ...

Shares of genetic testing company Natera (NASDAQ:NTRA). jumped 5.2% in the afternoon session after stocks rebounded, ...

Following a successful return to racing, 2024 Horse of the Year Thorpedo Anna has found herself back at the top of the racing ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced the enrollment of the first patients in the HEROES clinical trial. HEROES is a multi-center, phase II ...

Thoroughbred Aftercare Alliance will have a booth set up where horseplayers are encouraged to stop by and learn more about ...

While the top- and bottom-line numbers for Natera (NTRA) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare ...

Shares of Natera, Inc. (NASDAQ:NTRA – Get Free Report) saw strong trading volume on Tuesday after Morgan Stanley raised their price target on the stock from $176.00 to $185.00. Morgan Stanley ...

HEROES is Natera's first clinical trial using Signatera to guide de-escalation of therapy in patients with metastatic HER2+ breast cancer Approximately 170 patients are expected to enroll in up ...

Journalism's 108 Beyer earned in winning the G2 San Felipe had the Michael McCarthy trainee jumping to second position in ...

StockNews.com lowered shares of Natera (NASDAQ:NTRA – Free Report) from a hold rating to a sell rating in a research report released on Monday morning. Other equities analysts have also issued reports ...

Topping a field of more than 5,500 of the nation’s best horseplayers over a 12-month period, Brett Wiener of Clearwater, Fla.